Survivorship After Cardiogenic Shock
- PMID: 39836757
- PMCID: PMC11974375
- DOI: 10.1161/CIRCULATIONAHA.124.068203
Survivorship After Cardiogenic Shock
Abstract
Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%. After their index hospitalization, however, survivors of CS may continue to face cardiac as well as extracardiac sequelae of these therapies and complications for years to come. Most studies in CS have focused primarily on survival, with limited data on long-term recovery measures among survivors. In other forms of critical illness, research indicates that many intensive care unit survivors experience impairments in multiple domains, such as cognitive function, physical ability, and mental health. These impairments, collectively referred to as Post-Intensive Care Syndrome, in turn impact survivors' quality of life and future prognosis. This review identifies unique aspects of CS-related survivorship, highlights lessons learned from other forms of critical illness, and outlines future research directions to determine specific strategies to enhance recovery and survivorship after CS.
Keywords: cognitive dysfunction; heart failure; intensive care units; shock, cardiogenic; survivorship.
Conflict of interest statement
Dr Hall is supported by the National Institutes of Health/National Heart Lung and Blood Institute (grant 5T32HL125247-8). Dr Agarwal is supported by grants R01-HL153311 and R01-NS127959 from the National Institutes of Health. Dr Cullum reports serving as the Scientific Director of the Texas Alzheimer’s Research and Care Consortium and receiving royalties from the Texas Functional Living Scale, published by Pearson, Inc. Dr Ely reports receiving research funding from the National Institutes of Health and the VA. The other authors report no relevant disclosures.
References
-
- Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, Erne P, Rickli H, Pilgrim T, AMIS Plus Registry Investigators. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv. 2019;12:e007293. doi: 10.1161/CIRCINTERVENTIONS.118.007293 - DOI - PubMed
-
- Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3:e000590. doi: 10.1161/JAHA.113.000590 - DOI - PMC - PubMed
-
- Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, Burrows N, McLean A, Vilas-Boas F, Mebazaa A. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011;37:619–626. doi: 10.1007/s00134-010-2113-0 - DOI - PubMed
-
- Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19:1242–1254. doi: 10.1002/ejhf.890 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources